Barclays
HIMS icon

Barclays’s Hims & Hers Health HIMS Stock Holding History

Barclays’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-154,500
Closed -$3.21M – 5469
2026
Q1 		$3.21M Sell
154,500
-94,500
-38% -$2.23M ﹤0.01% 2087
2025
Q4 		$8.09M Buy
+249,000
New +$10.7M ﹤0.01% 1854
2025
Q3 		– Sell
-78,300
Closed -$3.9M – 5591
2025
Q2 		$3.9M Buy
+78,300
New +$3.54M ﹤0.01% 2330

Other funds holding HIMS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Greenfield Seitz Capital Management
Greenfield Seitz Capital Management Dallas, Texas $346M AUM 27.05% 1-Year Est. Return

Barclays's HIMS Position: Q3 2026 in Review

Barclays increased its Hims & Hers Health (HIMS) stake by 28% in Q3 2026, buying an estimated $7.4M and bringing the position to 1,102,127 shares worth $32.8M. The position accounts for 0.01% of the portfolio, ranked #984.

Barclays first reported a position in HIMS in Q1 2022 and has held it in 19 quarters since. The position peaked at $37.4M in Q3 2025. 234 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Barclays held 1,102,127 shares of Hims & Hers Health worth $32.8M as of Q3 2026.
  • Barclays bought 241,121 Hims & Hers Health shares in Q3 2026, an estimated $7.4M.
  • Hims & Hers Health made up 0.01% of Barclays's portfolio in Q3 2026, its #984 holding.
  • Barclays first reported a position in Hims & Hers Health in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Hims & Hers Health position peaked at $37.4M in Q3 2025.
  • 234 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.